Osler Diagnostics Funding: $170M Raised, Series C (2022)
Osler Diagnostics is based in Oxford, England. It has raised $170M in total funding. Latest round: Series C.
Osler Diagnostics funding overview
Osler Diagnostics is based in Oxford, England. Osler Diagnostics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2022. The round record for Osler Diagnostics runs through 2022; nothing later has been disclosed. Investors on record include M&G Investments, Oxford Science Enterprises, Braavos Investment Advisers, Lansdowne Partners, Oxford Sciences Innovation, Bio-Rad Laboratories. 6 distinct backers are named across the disclosed rounds.
Osler Diagnostics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Osler Diagnostics?
M&G Investments, Oxford Science Enterprises, Braavos Investment Advisers, Lansdowne Partners, Oxford Sciences Innovation, Bio-Rad Laboratories are named among the investors backing Osler Diagnostics.
What was the latest Osler Diagnostics funding round?
The most recent disclosed round is a Series C, announced in November 2022.
Where is Osler Diagnostics based?
Osler Diagnostics is based in Oxford, England.
When did Osler Diagnostics last raise?
The last disclosed Osler Diagnostics round closed in November 2022 at Series C.
Totals shown for Osler Diagnostics aggregate every disclosed round on file. To see how that compares, browse the companies in Oxford and the investors behind them below.
